Dr. Alison Moore serves as the President and Chief Executive Officer of Codexis, having officially assumed the executive leadership role in November 2025 after successfully serving as the company's Chief Technical Officer and as a member of its board of directors. Bringing extensive biotechnology and biomanufacturing executive experience—including senior leadership positions at prominent life science enterprises such as Allogene Therapeutics and Amgen—she guides the company's overarching strategic vision, proprietary enzyme engineering initiatives, and the commercial scaling of its ECO Synthesis technology platform to meet future biopharmaceutical manufacturing demands.